Stocktoria
Warby Parker Inc. WRBY
NYSE · XNYS · stock · Ophthalmic Goods · website · IPO 2021-09-29
Warby Parker Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 54.0% | 55.3% | 54.5% | 57.0% | 58.8% |
| Operating margin | -0.6% | -3.9% | -10.7% | -18.6% | -26.6% |
| Net margin | 0.2% | -2.6% | -9.4% | -18.5% | -26.7% |
| FCF margin | 5.0% | 4.5% | 1.1% | -8.3% | -14.9% |
| Return on assets | 0.2% | -3.0% | -10.9% | -19.4% | -32.7% |
| Return on equity | 0.4% | -6.0% | -20.9% | -38.5% | -50.4% |
| Current ratio | 2.35 | 2.50 | 2.35 | 2.27 | 2.78 |
| Revenue growth | 13.0% | 15.2% | 12.0% | 10.6% | 37.4% |
Source: SEC EDGAR filings · CIK 0001504776 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.